Friday, September 05, 2008

Opexa Therapeutics And Myelin Repair Foundation Partner On Novel Multiple Sclerosis Research Program - Biogen to test Tysabri as a cancer treatment

Opexa Therapeutics And Myelin Repair Foundation Partner On Novel Multiple Sclerosis Research Program
Medical News Today Fri, 05 Sep 2008 6:17 AM PDT
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, announced the establishment of a novel MS research partnership with the Myelin Repair Foundation, Inc. (MRF).http://www.medicalnewstoday.com/articles/120376.php


Opexa, Myelin Repair partner on sclerosis research programme
PharmaBiz Fri, 05 Sep 2008 3:39 AM PDT
Opexa Therapeutics, Inc, a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, announced the establishment of a novel MS research partnership with the Myelin Repair Foundation, Inc (MRF). As part of this collaboration, Opexa and the MRF will work to identify therapeutically relevant ...
http://www.pharmabiz.com/article/detnews.asp?articleid=45947

Pregabalin as Efficacious as Naltrexone in Alcohol Dependence but Superior in Patients With Psychiatric Comorbidity: Presented at ECNP

  • (DGDispatch) http://www.docguide.com/gpc.nsf/doc?CreateDocument&n=22&id=66B03AF3258F523F85256FAA0021D865&t=00-00-00;AM&l=email-09-04-2008w&u=/redirect.nsf/we_link?OpenForm&id=66B03AF3258F523F85256FAA0021D865&ntype=int&newsid=852571020057CCF6852574B6007A90FC

    Biogen to test Tysabri as a cancer treatment
    Bizjournals.com - Charlotte,NC,USA
    Biogen Idec has begun testing the multiple sclerosis drug Tysabri as a treatment for blood cancer. Cambridge, Mass.-based Biogen (Nasdaq: BIIB) and ...
    http://www.bizjournals.com/triangle/stories/2008/09/01/daily34.html
  • Biogen’s battered MS drug in cancer treatment trials
    Mass High Tech - MA, USA
    By Mass High Tech Staff Cambridge biotech Biogen Idec and Irish drug partner Elan Corp. began testing their multiple sclerosis drug Tysabri in a phase 2/3 ...
    http://www.masshightech.com/stories/2008/09/01/daily51-Biogens-battered-MS-drug-in-cancer-treatment-trials.html

    Biogen Idec and Elan Corp Announce Start of Trials with Tysabri as ...
    Network Médica - Buenos Aires,Argentina
    Elan Corp PLC and Biogen Idec Inc announced the start of Phase I/II trials with Tysabri, their multiple scelerosis and Crohn´s disease drug, with the goal ...
    http://en.networkmedica.com/noticia/seccion/128/articulo/20985/Biogen_Idec_and_Elan_Corp_Announce_Start_of_Trials_with_Tysabri_as_Cancer_Treatment.html

    Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI® in ...
    elEconomista.es - Madrid,Madrid,Spain
    The first dose of TYSABRI was administered yesterday in the trial. The objectives of this Phase I/II study are to evaluate the safety and potential ...
    http://www.eleconomista.es/empresas-finanzas/noticias/736123/09/08/Elan-and-


    Biogen Idec testing Tysabri as a cancer treatment
    Boston Globe - United States
    Tysabri is already approved for treating multiple sclerosis and Crohn's disease, but there have been setbacks. Tysabri was originally launched in 2004 but ...
    http://www.boston.com/business/ticker/2008/09/biogen_idec_tes.html

    Biogen and Elan start testing Tysabri in cancer
    Forbes - NY,USA
    PLC said they have started the first clinical trial of their multiple sclerosis and Crohn's disease drug Tysabri as a treatment for cancer. ...
    http://www.forbes.com/feeds/ap/2008/09/05/ap5392590.html

    Elan, Biogen launch Tysabri trial in oncology
    Reuters UK - UK
    I: Quote, Profile, Research) have launched the first clinical trial of their multiple sclerosis drug Tysabri for patients with relapsed or refractory ...
    http://uk.reuters.com/article/hotStocksNews/idUKWLA907820080905

    Tysabri clinical study underway
    Hays Pharma - London,Greater London,UK
    Elan Corporation and Biogen Idec have announced that the first clinical trial of Tysabri has begun. The phase-one and phase-two studies seek to assess the ...
    http://www.hayspharma.com/news/news-item/18765851

    Elan, Biogen launch Tysabri trial in oncology
    Reuters - USA
    I: Quote, Profile, Research, Stock Buzz) have launched the first clinical trial of their multiple sclerosis drug Tysabri for patients with relapsed or ...
    http://www.reuters.com/article/marketsNews/idUSWLA907820080905

    Market Report -- In Play (WIRES)
    MSN Money - USA
    On The Wires Elan (ELN) and Biogen Idec (BIIB) announce the initiation of the first clinical trial of TYSABRI in oncology; the first dose of TYSABRI was ...
    http://news.moneycentral.msn.com/provider/providerarticle.aspx?feed=BCOM&date=20080905&id=9106101

    Symptoms and Management


    Dr. Devonshire

    Director of the University of British Columbia MS Clinic


    View BIO

    Q :

    I have been diagnosed with MS and I experience a feeling of having bands around my legs. I am a science major and understand the cause of MS but I am curious to what EXACTLY causes these bands.
    (physiology)

    A :

    Banding is a common, but often overlooked MS symptom. It feels like there is something tight around a limb or trunk. The muscles are not actually tight, nor is there any swelling. The sensation of banding is seen in both in MS and spinal cord injury, We therefore assume that the anatomic localization for banding is lesions of the spinal cord. Although the exact physiology is not known, it is likely a form of reduced or altered sensory messaging from the spinal cord to the area of the brain that perceives sensation. Something similar would be the way your face feel ”fat” when you have dental freezing.
    9/5/2008 10:05:52 PM

    More answers from Dr. Virginia Devonshire
    More answers in the category: Symptoms and Management

    DISCLAIMER: Please be aware that this information does not necessarily represent the opinion of the MS Society of Canada, and is not intended as medical advice. For specific advice and opinion, always consult a physician.
    © 2008 Multiple Sclerosis Society of Canada | www.mssociety.c

    http://www.msanswers.ca/QuestionView.aspx?L=2&QID=2213



    Update on Relapsing-Remitting MS: B-cell Depletion with Rituximab
    IIn this article review, Dr. Bruce Cree comments on a recent clinical trial that explored the use of rituximab, a monoclonal antibody directed against CD20+ B lymphocytes, as therapy for patients with multiple sclerosis.
    Source:
    Projects In Knowledge
    http://broadcaster.medpagetoday.com/t?r=2&c=2020&l=15&ctl=DCE0:961584531C0AE512FC05815C81B36A4B

    Accelerated Cure Project informal status for the month of August 2008


    >>> Research
    Repository:
    o As of the end of August, we had enrolled 1294 subjects into our
    repository.
    o We distributed data from our repository database to Alan Ruttenberg
    of ScienceCommons, who is developing methods for structuring and
    analyzing data and would like to apply these methods to better
    understanding MS.
    o We received one new proposal for use of repository samples and data
    and are currently reviewing it.
    o Sara, Art and Hollie had a phone call with Phil DeJager and Ben
    Greenberg about potential future collaborations.
    o Hollie talked with Silke Schmidt from Duke University to get her
    advice about using our repository for gene/environment studies.
    o Hollie and Art spoke with Nancy Barrand and Theresa Dixon of the
    Robert Wood Johnson Foundation, who wanted to know more about the
    repository.
    Other Science Efforts:
    o A newly updated version of our MS genetic studies database has been
    posted and can be found here:
    http://www.acceleratedcure.org/downloads/phase2-genetic-studies.xls
    o Hollie and Art had lunch with scientific advisor Maria Lopez-Bresnahan
    to learn about her new job at i3 Research.
    >>> Education
    o Poll - What is your natural hair color?
    http://msnews.acceleratedcure.org/node/3367

    o We continue our daily MS News updates
    http://msnews.acceleratedcure.org
    >>> Fundraising
    o Nothing new to report
    >>> Community Building
    o As always, a few more T-shirt pictures are available:
    http://www.acceleratedcure.org/events/tshirt.php
    >>> Upcoming Events
    Detailed information about all of our upcoming events can be found on
    our web site:

    http://www.acceleratedcure.org/events/calendar.php



    Statin Therapy Underused in Elderly Patients With Atherosclerosis

    CHICAGO -- August 28, 2008 -- Use of statin therapy to combat the adverse cardiovascular outcomes from atherosclerosis is underused is elders, according to new research published in the September 2008 issue of the Journal of Vascular Surgery. In a 10-year population-based study (1995-2005) of 343,154 elderly patients in Ontario, ...Full Story
    http://www.docguide.com/gpc.nsf/doc?

    CreateDocument&n=22&id=66B03AF3258F523F85256FAA0021D865&t=00-00-00;AM&l=email-09-04-2008w&u=/redirect.nsf/we_link?OpenForm&id=66B03AF3258F523F85256FAA0021D865&ntype=int&newsid=852571020057CCF6852574B3006FC9C9

    Mental Skills Decline in Elders Years Before Death, Even Without Dementia

  • (DGNews)
    http://www.docguide.com/gpc.nsf/doc?CreateDocument&n=22&id=66B03AF3258F523F85256FAA0021D865&t=00-00-00;AM&l=email-09-04-2008w&u=/redirect.nsf/we_link?OpenForm&id=66B03AF3258F523F85256FAA0021D865&ntype=int&newsid=852571020057CCF6852574B3006F9DCB
    Treadmill Exercise Retrains Brain and Body of Stroke Victims, Even Years After Stroke
  • (DGNews) http://www.docguide.com/gpc.nsf/doc?CreateDocument&n=22&id=66B03AF3258F523F85256FAA0021D865&t=00-00-00;AM&l=email-09-04-2008w&u=/redirect.nsf/we_link?OpenForm&id=66B03AF3258F523F85256FAA0021D865&ntype=int&newsid=852571020057CCF6852574B4004955BA
  • 0 Comments:

    Post a Comment

    Links to this post:

    Create a Link

    << Home